Your Messages Inbox
Your Article Summary
See Latest ArticlesRevisiting the level of evidence in randomized controlled clinical trials: A simulation approach
Contemporary Clinical Trials , 08/21/09
Bajard A et al. – In RCTs, the hierarchy of confounding factors differs according to the type of blinding and the current short list of components of the strength of evidence (poorly concealed randomization and lack of blinding) appears to be incomplete.
Related Articles
Which interventions are best for alleviating nipple pain in nursing mothers?
The Journal of Family Practice, 11/05/09
Relevance Score: 89%
Review: limited evidence that psychological therapies are of benefit for adults with chronic pain
Evidence-Based Mental Health, 10/28/09
Relevance Score: 88%
Review: differences in efficacy and acceptability exist for 12 new-generation antidepressants for major depression
Evidence-Based Medicine, 10/26/09
Relevance Score: 88%
Special care units for dementia individuals with behavioural problems
Cochrane Reviews, 10/21/09
Relevance Score: 84%
Race Not Reported In Over 50 Percent Of Randomized Clinical Trials For Cardiovascular Disease
ScienceDaily, 10/14/09
Relevance Score: 84%
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care
Amgen, 12/11/09
A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial origin
Cancer Chemotherapy and Pharmacology, 12/11/09
Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Repligen, 12/10/09
Article Search
Sponsor